Faith Concepts in Psychology: Three 30-Year Definitional Content Analyses von Harris, Kevin A, Howell, Desiree S, Spurgeon, Don W

Volltext

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia von Brown, Jennifer R., Byrd, John C., Coutre, Steven E., Benson, Don M., Flinn, Ian W., Wagner-Johnston, Nina D., Spurgeon, Stephen E., Kahl, Brad S., Bello, Celeste, Webb, Heather K., Johnson, Dave M., Peterman, Sissy, Li, Daniel, Jahn, Thomas M., Lannutti, Brian J., Ulrich, Roger G., Yu, Albert S., Miller, Langdon L., Furman, Richard R.

Volltext

A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL) von Kahl, Brad S., Spurgeon, Stephen E., Furman, Richard R., Flinn, Ian W., Coutre, Steven E., Brown, Jennifer R., Benson, Don M., Byrd, John C., Peterman, Sissy, Cho, Yoonjin, Yu, Albert, Godfrey, Wayne R., Wagner-Johnston, Nina D.

Volltext

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma von Flinn, Ian W., Kahl, Brad S., Leonard, John P., Furman, Richard R., Brown, Jennifer R., Byrd, John C., Wagner-Johnston, Nina D., Coutre, Steve E., Benson, Don M., Peterman, Sissy, Cho, Yoonjin, Webb, Heather K., Johnson, David M., Yu, Albert S., Ulrich, Roger G., Godfrey, Wayne R., Miller, Langdon L., Spurgeon, Stephen E.

Volltext

5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, CAL-101 (GS... von Brown, Jennifer R, Jahn, Thomas M, Furman, Richard R, Leonard, John P, Spurgeon, Stephen E, Byrd, John C, Benson, Don M, Coutre, Steven E, Wagner-Johnston, Nina D, Flinn, Ian W, Kahl, Brad S, Schreeder, Marshall T, de Vos, Sven, Holes, Leanne M, Peterman, Harriet (Sissy), Johnson, Dave M, Miller, Langdon L

Volltext

CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Demonstrates Clinical Activity and Pharmacodynamic Effects In Patients with Relapsed or Refractory C... von Furman, Richard R., Byrd, John C., Brown, Jennifer R, Coutre, Steven E., Benson, Don M, Wagner-Johnston, Nina D., Flinn, Ian W., Kahl, Brad S., Spurgeon, Stephen E., Lannutti, Brian, Giese, Neil A., Webb, Heather K, Ulrich, Roger G, Peterman, Sissy, Holes, Leanne M., Yu, Albert S

Volltext

Clinical Safety and Activity In a Phase 1 Study of CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, In Patients with Relapsed or Refractory Non-Hodgk... von Kahl, Brad, Byrd, John C., Flinn, Ian W., Wagner-Johnston, Nina, Spurgeon, Stephen, Benson, Don M, Furman, Richard R., Brown, Jennifer R, Coutre, Steven, Lannutti, Brian, Giese, Neil A., Ulrich, Roger G, Webb, Heather K, Peterman, Sissy, Holes, Leanne, Yu, Albert S

Volltext

Evidence of Clinical Activity in a Phase 1 Study of CAL-101, An Oral P110Δ Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase, in Patients with Relapsed or Refractory B-C... von Flinn, Ian W, Byrd, John C., Furman, Richard R, Brown, Jennifer R, Benson, Don M, Coutre, Steven E, Kahl, Brad S, Smith, B. Douglas, Wagner-Johnston, Nina D., Spurgeon, Stephen E, Giese, Neill A., Yu, Albert S

Volltext